Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Reviews in Endocrine and Metabolic Disorders

Issue 1/2013

Vascular Endothelium in Diabetes and its Potential as a Therapeutic Target

Content (11 Articles)

The vascular endothelium in diabetes and its potential as a therapeutic target

Zhenqi Liu

Role of insulin resistance in endothelial dysfunction

Ranganath Muniyappa, James R. Sowers

The endothelium in diabetes: Its role in insulin access and diabetic complications

Cathryn M. Kolka, Richard N. Bergman

The endothelial cell: An “early responder” in the development of insulin resistance

Eugene J. Barrett, Zhenqi Liu

Microvascular dysfunction: An emerging pathway in the pathogenesis of obesity-related insulin resistance

Dennis M. J. Muris, Alfons J. H. M. Houben, Miranda T. Schram, Coen D. A. Stehouwer

Endothelial dysfunction in (pre)diabetes: Characteristics, causative mechanisms and pathogenic role in type 2 diabetes

Etto C. Eringa, Erik H. Serne, Rick I. Meijer, Casper G. Schalkwijk, Alfons J. H. M. Houben, Coen D. A. Stehouwer, Yvo M. Smulders, Victor W. M. van Hinsbergh

Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction

Ping Gu, Aimin Xu

Lipotoxicity contributes to endothelial dysfunction: A focus on the contribution from ceramide

J. David Symons, E. Dale Abel

The microcirculation in adipose tissue inflammation

Rosario Scalia

Type 2 diabetes mellitus and exercise impairment

Jane E. B. Reusch, Mark Bridenstine, Judith G. Regensteiner

The vascular endothelium in diabetes—a therapeutic target?

Kieren J. Mather

Dec 12
Issue: 4/2012
Menstruation
Jun 13
Issue: 2/2013
"HIV Related Endocrinopathies" and "Mass Spectrometry in Endocrinology"

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits